Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Van Ness

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Blood|November 15, 1995
Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study GroupN E Kay, M M Oken, N Bone, et al.
Blood|October 1, 1992
Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patientsD Billadeau, L Quam, W Thomas, et al.
British Journal of Haematology|March 21, 1998
T-helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93N E Kay, T Leong, N Bone, et al.
Leukemia|June 4, 2013
Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomibH A F Stessman, A Mansoor, F Zhan, et al.
Blood|July 1, 1996
Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myelomaD Billadeau, B Van Ness, T Kimlinger, et al.
Blood|July 1, 1997
Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trialN E Kay, T Leong, R A Kyle, et al.
Leukemia & Lymphoma|October 8, 1999
Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?P R Greipp, M C Trendle, T Leong, et al.
Immunobiology|August 1, 1992
Lymphocyte Fc receptors: the immunobiology and pathology of CD23R G Lynch, M Sandor, R Nunez, et al.
British Journal of Haematology|June 10, 2000
Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patientsR Fonseca, M C Trendle, T Leong, et al.
Blood|October 1, 1996
Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III TrialP Liu, T Leong, L Quam, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Blood|November 15, 1995
Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study GroupN E Kay, M M Oken, N Bone, et al.
Blood|October 1, 1992
Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patientsD Billadeau, L Quam, W Thomas, et al.
British Journal of Haematology|March 21, 1998
T-helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93N E Kay, T Leong, N Bone, et al.
Leukemia|June 4, 2013
Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomibH A F Stessman, A Mansoor, F Zhan, et al.
Blood|July 1, 1996
Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myelomaD Billadeau, B Van Ness, T Kimlinger, et al.
Blood|July 1, 1997
Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trialN E Kay, T Leong, R A Kyle, et al.
Leukemia & Lymphoma|October 8, 1999
Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?P R Greipp, M C Trendle, T Leong, et al.
Immunobiology|August 1, 1992
Lymphocyte Fc receptors: the immunobiology and pathology of CD23R G Lynch, M Sandor, R Nunez, et al.
British Journal of Haematology|June 10, 2000
Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patientsR Fonseca, M C Trendle, T Leong, et al.
Blood|October 1, 1996
Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III TrialP Liu, T Leong, L Quam, et al.
Pageof 7